Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
BioXcel Therapeutics, Inc. (BTAI) had Return on Investments of -115.44% for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$0.37M |
|
$-10.86M |
|
$0.83M |
|
$-0.47M |
|
$10.86M |
|
$-10.49M |
|
$-0.37M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-10.49M |
|
$-10.42M |
|
2.54M |
|
2.54M |
|
$-1.11 |
|
$-1.11 |
|
| Balance Sheet Financials | |
$37.39M |
|
$0.47M |
|
$0.94M |
|
$38.34M |
|
$22.23M |
|
$102.51M |
|
$109.21M |
|
$131.44M |
|
$-93.10M |
|
$-93.10M |
|
$-93.10M |
|
3.10M |
|
| Cash Flow Statement Financials | |
$-72.03M |
|
-- |
|
$36.66M |
|
$65.22M |
|
$29.85M |
|
$-35.37M |
|
$6.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.68 |
|
-- |
|
-- |
|
10.90 |
|
-1.10 |
|
-127.05% |
|
-2866.94% |
|
-2866.94% |
|
-- |
|
-2966.94% |
|
-2966.94% |
|
$-72.03M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
1.22 |
|
2.79 |
|
32.21 |
|
11.66% |
|
11.66% |
|
-28.32% |
|
|
Return on Investments |
-115.44% |
$-30.01 |
|
$-28.41 |
|
$-28.41 |
|